Mishra S, Parthsarthy T. R, Gita B, Chandran C. R, Lal K. Periodontal Management of HIV-infected Patients : An Overview. Biomed Pharmacol J 2015;8(October Spl Edition)

---

Manuscript received on :
Manuscript accepted on :
Published online on: 21-01-2016

---

How to Citeclose    |   Publication History close

 Views: (Visited 889 times, 1 visits today)    PDF Downloads: 882

Sudhakar Mishra¹, T.R.Parthsarthy², Bagavad Gita³, Chithra R.Chandran² And Kanhaiya Lal¹

¹Department of Oral and Maxillofacial Surgery, Tagore Dental College and Hospital, Rathinamangalam, Melakottaiyur Post, Chennai – 600127, India ²Department of Periodontics, Tagore Dental College and Hospital, Rathinamangalam, Melakottaiyur Post, Chennai - 600127, India. ³Department of Periodontics, Sree Balaji Dental College & Hospital, Bharath University, Chennai - 600100, India.

DOI : https://dx.doi.org/10.13005/bpj/768

Abstract

Recognition and diagnosis of the general oral manifestations and specific periodontal manifestations of HIV infection will continue to be a major responsibility of the dental practitioner. By combining local and systemic therapy aimed at both preventing and treating oral lesions and periodontal diseases, combined with new systemic antiviral and vaccine therapies, dental and medical practitioners may together help reduce both the dental morbidity and the overall patient morbidity in the HIV infected patient. With the advent of newer pharmacological approaches to the treatment of human immunodeficiency virus (HIV) infection, the incidence and progression of both atypical and conventional periodontal diseases are changing. While the accepted approaches to treating the spectrum of periodontal diseases in HIV patients remain essentially unchanged over the past 15 years, the impact of newer systemic therapies on patient immunocompetence may influence treatment decisions.

Keywords

HIV; periodontitis,immunocompetence; systemic antiviral and vaccine therapies; highlyactiveantiretroviraltherapy